Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.
Jun WangNa SunThomas KunzkeJian ShenAnnette FeuchtingerQian WangRaphael MeixnerRonan Le GleutIvonne HaffnerBirgit LuberFlorian LordickAxel K WalchPublished in: British journal of cancer (2024)
The patient cohort was conducted from a multicentre observational study (VARIANZ;NCT02305043).